These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1980362)

  • 1. Dopamine receptor agonists and antagonists.
    Kohli JD
    Proc West Pharmacol Soc; 1990; 33():21-7. PubMed ID: 1980362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current developments in the pharmacology of dopaminergic receptors (I)].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.
    Fuxe K; Ungerstedt U
    Med Biol; 1974 Feb; 52(1):48-54. PubMed ID: 4157329
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current developments in the pharmacology of dopaminergic receptors (II)].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(2):393-4. PubMed ID: 2573123
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current developments in the pharmacology of the dopaminergic receptors. III].
    Nechifor M; Lucaci L
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):510, 516, 566. PubMed ID: 2576889
    [No Abstract]   [Full Text] [Related]  

  • 6. Repeated administrations of dopamine receptor agents affect lithium-induced state-dependent learning in mice.
    Zarrindast M; Madadi F; Ahmadi S
    J Psychopharmacol; 2009 Aug; 23(6):645-51. PubMed ID: 18635706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression estimation from grouped observations applied to structurally diverse D2-receptor antagonists.
    Mager PP; Rothe H
    Pharmazie; 1990 Jun; 45(6):424-33. PubMed ID: 1976263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light modulates dopamine-regulated Walsh inhibitor activity and dopamine-dependent cyclic AMP accumulation in the rabbit retina.
    Nowak JZ; Zawilska J; Sek B; Schorderet M
    Pol J Pharmacol Pharm; 1990; 42(5):457-70. PubMed ID: 1983030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dopamine receptors in gastrointestinal motility.
    Dhasmana KM; Banerjee AK; Zhu YN; Erdmann W; Parmar SS; Salzman SK
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):485-8. PubMed ID: 2571179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of dopamine receptor agonists.
    Murphy MB
    Proc West Pharmacol Soc; 1990; 33():31-5. PubMed ID: 1980363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral dopaminergic nerves.
    Bell C
    Pharmacol Ther; 1989; 44(2):157-79. PubMed ID: 2577510
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine: receptors and clinical applications.
    Goldberg LI
    Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex.
    Charbit AR; Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):752-63. PubMed ID: 19657051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
    Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M
    Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Satoh Y; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.
    Scatton B
    J Pharmacol Exp Ther; 1982 Jan; 220(1):197-202. PubMed ID: 6118430
    [No Abstract]   [Full Text] [Related]  

  • 19. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.
    De Lean A; Kilpatrick BF; Caron MG
    Mol Pharmacol; 1982 Sep; 22(2):290-7. PubMed ID: 7144730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.